Jade Therapeutics

About:

Jade Therapeutics develops locally administered, polymer-based products designed to treat poorly-served ophthalmic indications.

Website: http://www.jadetherapeutics.com/

Top Investors: National Science Foundation

Description:

Jade Therapeutics develops ophthalmic sustained-release drug delivery platforms. The company focuses on the development of locally administered, sustained-release therapeutics that improve corneal healing following damage from disease or injury and improve visual function and quality of life. Its product delivers recombinant human growth hormone, a well-characterized biologic, that has healing properties via the activation and recruitment of key cells involved in the tissue-building process.

Total Funding Amount:

$1.06M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2011-01-01

Founders:

Barbara Wirostko, MaryJane Rafii

Number of Employees:

1-10

Last Funding Date:

2014-11-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai